Canopus Biopharma and leading chinese researcher, Dr. Jiahai Lu, team up to treat avian influenza with StatC, to prevent possibl

2008-08-13 アップロード · 24 視聴

An internationally renowned avian influenza expert today hailed "encouraging and exciting" results from experiments conducted by his research team. This study demonstrated impressive efficacy of a novel statin/caffeine combination, StatC™ in the treatment and prevention of H5N1, H1N1 and H3N2 in a mouse model.

Dr. Jiahai Lu, from the School of Public Health, Sun Yat-sen University in Guangzhou, China, has published extensively in the field of avian influenza, and has been researching the breakthrough compound StatC™ for the past two years on behalf of Canopus BioPharma (OTCPK:CBIA), a US corporation who discovered and patented the potential of this antiviral candidate.

To view Multimedia News Release go to, http://www.prnewswire.com/mnr/canopusbiopharma/34441/

tag·AVIAN INFLUENZA CANOPUS,Multivu,34441

恐れ入りますが、4月17日から5月08日までコメントの機能のみテストを実施します。ですので、一時的にコメント欄はご利用できません。ご了承ください。

非会員の場合は、名前/パスワードを入力してください。

今日のアクセス
5
全体アクセス
136,335
チャンネル会員数
35

My Video

リスト形式で表示 碁盤形式で表示